Strata Oncology: Funding, Investors & Team (Sep 2026)
Strata Oncology is a precision oncology company dedicated to transforming cancer care by expanding patient access to precision medicine clinical trials and accelerating drug approval. Strata's national precision oncology platform serves the needs of patients, providers and drug developers by providing a link from patient screening to streamlined enrollment in mutation-matched clinical trials. Follow us on Twitter @StrataOncology.
Strata Oncology has raised $90.0M across 1 funding round on record, the most recent a Series C of $90.0M announced in Jul 2021.
That round is above the $8.0M median round size for Biotechnology companies tracked on FundedIQ over the last two years.
Strata Oncology Company Profile and Key Stats
Latest funding round on record: Jul 2021.
Strata Oncology Funding Rounds
Strata Oncology Founders and Leadership Team
Contact details for the Strata Oncology team: 1 of 1 has an email address on file.
Start 14-day free trial →Strata Oncology Funding Compared to Other Biotechnology Startups
Strata Oncology's latest round of $90.0M is above the median round in Biotechnology. Medians cover the last 24 months of disclosed rounds.
Funded Startups Like Strata Oncology in Biotechnology and Ann Arbor
Companies Similar to Strata Oncology
Superluminal Medicines is a biotech company that specializes in rapidly developing new drugs through a…
Senticell's mission is to fully harness the unique immune and genetic functions of RBC to transform and treat…
ImmunoPhotonics, Inc. develops immunotherapy-based treatments for cancer. ImmunoPhotonics, Inc. has a…
EIT Pharma is a commercial-stage biotechnology company focuses on developing and commercializing…
Halia Therapeutics is a biopharmaceutical company in the preclinical stage that is developing new treatments…
Noveome Biotherapeutics, Inc. is an advanced biopharmaceutical company that focuses on groundbreaking…
XiltriX North America is an information technology company that specializes in monitoring, predictive…
Novir is an emerging diagnostic biotechnology company with an unmatched team of professionals and trusted…
Abcuro’s mission is to develop a new class of immune-modulatory bio-therapeutics for treating both…
Georgiamune Inc. is a privately-owned biotechnology company that specializes in advanced immunotherapy…
Bridge to Life was founded with the mission of improving organ transplants by licensing and developing new…
InduPro is a biotechnology firm that focuses on protein therapeutics and technologies related to cell-surface…
Strata Oncology Funding FAQs
What does Strata Oncology do?
Strata Oncology is a precision oncology company dedicated to transforming cancer care by expanding patient access to precision medicine clinical trials and accelerating drug approval. Strata's national precision oncology platform serves the needs of patients, providers and drug developers by providing a link from patient screening to streamlined enrollment in mutation-matched clinical trials. Follow us on Twitter @StrataOncology.
How much funding has Strata Oncology raised?
Strata Oncology has raised $90.0M across 1 round on record. The most recent is a Series C of $90.0M announced in Jul 2021.
When did Strata Oncology last raise funding?
Strata Oncology's most recent funding round on record is a Series C of $90.0M, announced in Jul 2021.
Who is the CEO of Strata Oncology?
Dan Rhodes is listed as CEO at Strata Oncology.
Where is Strata Oncology headquartered?
Strata Oncology is based in Ann Arbor, Michigan, United States.
How many employees does Strata Oncology have?
Strata Oncology is in the 51-100 employee band.
How does Strata Oncology's funding compare to other Biotechnology startups?
Strata Oncology's latest round of $90.0M is above the $8.0M median round size for Biotechnology companies on FundedIQ across 4,182 tracked companies over the last two years.
About FundedIQ's Strata Oncology Funding Data
FundedIQ tracks announced funding rounds and refreshes this profile every week. Round dates, stages and amounts are normalised to a single format, converted to US dollars, and de-duplicated: two records of the same round announced days apart are merged, and two genuinely different rounds are kept apart on the amounts they disclose. Amounts shown are the disclosed figures only — a round announced without a number is listed and excluded from the total rather than estimated.
Employee counts are reported bands, not exact headcounts. Founder and executive names carry the job title on record. Anything we do not hold for Strata Oncology is left off this page rather than filled in.
Know who just raised. Then know who to reach.
Every newly funded startup with its round, its investors and its founders: delivered weekly by email, or searchable in the app.
Alerts from $19/mo · Pro from $99/mo. Card required, nothing charged until day 15, and we email you 3 days before that.